HUTCHMED (China) Limited
HMDCF
$3.21
-$0.61-15.99%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | -3.60% | -3.60% | -53.05% | -53.05% | 113.41% |
Total Other Revenue | 21.10% | 21.10% | -21.10% | -21.10% | -- |
Total Revenue | 6.36% | 6.36% | -42.64% | -42.64% | 36.00% |
Cost of Revenue | -20.34% | -20.34% | -13.53% | -13.53% | 26.18% |
Gross Profit | 67.43% | 67.43% | -61.32% | -61.32% | -11.92% |
SG&A Expenses | -15.11% | -15.11% | -15.31% | -15.31% | 15.17% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | -14.48% | -14.48% | -20.90% | -20.90% | -8.48% |
Operating Income | 82.65% | 82.65% | -124.65% | -124.65% | 55.78% |
Income Before Tax | 124.49% | 124.49% | -83.13% | -83.13% | 65.60% |
Income Tax Expenses | 142.05% | 142.05% | 5.71% | 5.71% | -54.76% |
Earnings from Continuing Operations | 117.56% | 117.56% | -84.56% | -84.56% | 65.38% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -112.77% | -112.77% | 60.31% | 60.31% | 231.09% |
Net Income | 117.60% | 117.60% | -84.69% | -84.69% | 65.77% |
EBIT | 82.65% | 82.65% | -124.65% | -124.65% | 55.78% |
EBITDA | 88.64% | 88.64% | -118.42% | -118.42% | 56.99% |
EPS Basic | 117.59% | 117.59% | -84.82% | -84.82% | 66.01% |
Normalized Basic EPS | 135.16% | 135.16% | -83.49% | -83.49% | 69.54% |
EPS Diluted | 112.56% | 112.56% | -84.21% | -84.21% | 66.86% |
Normalized Diluted EPS | 134.25% | 134.25% | -83.41% | -83.41% | 69.54% |
Average Basic Shares Outstanding | 0.27% | 0.27% | 1.07% | 1.07% | 0.87% |
Average Diluted Shares Outstanding | 2.43% | 2.43% | 0.64% | 0.64% | 0.87% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |